Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Extracellular Vesicles: Applications in Regenerative Medicine"
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Regenerative Engineering".
Deadline for manuscript submissions: closed (21 April 2023) | Viewed by 7808
Special Issue Editors
Interests: extracellular vesicles; exosomes; mesenchymal stem cells; drug delivery; miRNA; cell based therapies; wound healing; neurodegenerative diseases; cardiovascular diseases; growth factors; regenerative medicine
Interests: antibiotic resistance; drug discovery
Interests: defense systems; toxin-antitoxin systems; bacterial stress adaptation; structural biology
Special Issue Information
Extracellular vesicles (EVs) represent a new frontier in biomedicine, opening up exciting new possibilities for advanced drug delivery and targeted release. They are a diverse group of membranous structures derived from cells. They include exosomes and microvesicles that originate in the endosomal system or are shed from the plasma membrane. Almost all cell types secrete these vesicles to facilitate a wide variety of cellular functions, including intercellular communication, angiogenesis, differentiation and proliferation, stress response, and immune signaling. This ability to participate in a variety of distinct processes is a result of EVs complexity, as they contain a variety of including proteins, signaling moieties, lipids, enzymes, cell surface receptors, transcription factors, cytokines, and nucleic acids. EVs’ advantageous biological properties, which include biocompatibility, stability, low toxicity, and efficient molecular cargo exchange, make them ideal candidates for tissue engineering and regenerative medicine. EV research has made significant progress in recent years, with the majority of studies focusing on the use of EV as drug delivery vehicles for non-native therapeutics such as nucleic acids, gene delivery via adeno-associated viruses, and small drug molecules.
Dr. Mangesh D. Hade
Dr. Timsy Bhando
Dr. Amar Deep
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- extracellular vesicles
- mesenchymal stem cells
- drug delivery
- cell-based therapies
- cell-based cancer therapies
- wound healing
- neurodegenerative diseases
- cardiovascular diseases
- growth factors
- regenerative medicine
- gene therapies